The MetroHealth System Signs Deal with Global Med Technologies(R), Inc. for Transfusion Management System DENVER, Dec. 7 /PRNewswire-FirstCall/ -- Wyndgate Technologies(R) ("Wyndgate"), a division of Global Med Technologies(R), Inc. (OTC:GLOB) (BULLETIN BOARD: GLOB) ("Global Med" or the "Company"), announced the signing of an agreement for SafeTrace Tx(R)*, its advanced transfusion management with The MetroHealth System in Cleveland, Ohio. Terms of the agreement were not disclosed. (Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) "The MetroHealth System is a very complex healthcare facility affiliated with Case Western Reserve University School of Medicine, and we needed a robust transfusion management system to manage the complexities of our transfusion service operation," said Carol Iaffaldano, Administrator, MetroHealth Department of Pathology. Ms. Iaffaldano added, "The comprehensive safety features in SafeTrace Tx and Wyndgate's extensive experience with installations in large and multi-facility organizations were an integral part of the reason that we selected Wyndgate to install its product in our transfusion service." "We are delighted that The MetroHealth System selected SafeTrace Tx to automate its transfusion service," said Wm. Scott Dustin, Vice President of Sale and Marketing at Global Med Technologies. Mr. Dustin added, "Our experience in the industry as a provider of blood bank solutions and the quality of our products are why our SafeTrace Tx advanced transfusion management system is in use in over 150 transfusion services ranging in size from small hospitals to large multi-facility healthcare networks as well as regional centralized transfusion services." Our product continues to gain recognition and acceptance as a leader in transfusion medicine automation. About The MetroHealth System The MetroHealth System is one of the nation's largest and most successful public health care providers, offering health care for the most critically injured trauma patients to skilled nursing care for the chronically ill. Affiliated with Case Western Reserve University since 1914, MetroHealth continues to build on its long-standing teaching reputation and research excellence, offering vital training and research opportunities for students and physicians. MetroHealth conducts cutting-edge research in biomedical sciences, particularly in the areas of cancer, heart, liver and kidney research. For more information, go to: http://www.metrohealth.org/. About Global Med Technologies, Inc. Global Med Technologies, Inc. is an international e-Health, medical information technology company, providing information management software products and services to the healthcare industry. Its Wyndgate Technologies division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Current clients of Wyndgate's products and services manage more than 3 million units of blood, or over 22% of the U.S. blood supply, each year. Wyndgate's products are also being implemented in Canada, the Caribbean and sub-Saharan Africa. Together, the SafeTrace Tx advanced transfusion management system and the SafeTrace(R) donor management system provide Vein-to-Vein(R) tracking from donor collection to patient transfusion. For more information about Global Med's products and services, please call 800-WYNDGATE or visit http://www.globalmedtech.com/, http://www.peoplemed.com/ and http://www.wyndgate.com/. Press Inquiries: Investor Inquiries: Wm. Scott Dustin Tom Marcinek Vice President of Sales and Marketing President and COO 916-404-8415 916-404-8413 This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release. * Patent Pending http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies, Inc. CONTACT: Press, Wm. Scott Dustin, Vice President of Sales and Marketing, +1-916-404-8415, , or Investors, Tom Marcinek, President and COO, +1-916-404-8413, , both of Global Med Technologies, Inc. Web site: http://www.metrohealth.org/ Web site: http://www.globalmedtech.com/

Copyright